Vor Biopharma Inc. held its annual meeting of stockholders on May 22, 2025. During the meeting, Matthew Patterson and Daniella Beckman were elected to the Board of Directors. An amendment to the company's Certificate of Incorporation to increase the number of authorized shares of common stock was approved. Additionally, the selection of Ernst & Young LLP as the independent registered public accounting firm for the year ending December 31, 2025, was ratified.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vor Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-125833), on May 23, 2025, and is solely responsible for the information contained therein.